Southpoint Capital Advisors LP - 31 Dec 2025 SCHEDULE 13G/A Report for Fennec Pharmaceuticals Inc. Common Shares, no par value (FENC)

Filing Manager
Southpoint Capital Advisors LP
Reporting Manager
Southpoint Master Fund, LP
Security
Fennec Pharmaceuticals Inc. Common Shares, no par value
Symbol
FENC
Shares outstanding
34,309,263 shares
Disclosed Ownership
2,744,741 shares
Ownership
8%
Form type
SCHEDULE 13G/A
Filing time
14 Jan 2026, 17:00:03 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Southpoint Master Fund, LP 8% 2,744,741 0 2,744,741 /s/ John S. Clark II By Southpoint GP, LP, its General Partner, by Southpoint GP LLC, its General Partner, by John S. Clark II, Managing Member
Southpoint Capital Advisors LP 8% 2,744,741 0 2,744,741 /s/ John S. Clark II By Southpoint Capital Advisors LLC, its General Partner, by John S. Clark II, Managing Member
Southpoint Capital Advisors LLC 8% 2,744,741 0 2,744,741 /s/ John S. Clark II John S. Clark II, Managing Member
Southpoint GP, LP 8% 2,744,741 0 2,744,741 /s/ John S. Clark II John S. Clark II, Managing Member
Southpoint GP, LLC 8% 2,744,741 0 2,744,741 /s/ John S. Clark II John S. Clark II, Managing Member
John S. Clark II 8% 2,744,741 0 2,744,741 /s/ John S. Clark II John S. Clark II, individually